🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wayne Harris

Emory University

ORCID: 0000-0002-1032-0265
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810”.

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810

Journal of Clinical Oncology(2024)10.1200/jco.23.01544
N/A
0.930DataRank · unranked
19 citations

Se Eun Kim, Wayne Harris, Sumanta K. Pal, Michael R. Pins, Jill Kolesar +13 more

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2697
N/A
0DataRank · unranked
14 citations

R. Donald Harvey, Bradley Curtis Carthon, Zhengjia Chen, Colleen Lewis, Hanna Collins +16 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738
N/A
0DataRank · unranked
1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.734
N/A
0DataRank · unranked
1 citations

Dylan J. Martini, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Elise Hitron +8 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563
N/A
0DataRank · unranked
1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868
N/A
0DataRank · unranked
43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932
N/A
0DataRank · unranked
18 citations

Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, Emilie Elise Hitron +11 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851
N/A
0DataRank · unranked
30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345
N/A
0DataRank · unranked
9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393
N/A
0DataRank · unranked
4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2
N/A
0DataRank · unranked
1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922
N/A
0DataRank · unranked
32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more